Yorke Justin W. - 27 Jan 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
27 Jan 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
18 Feb 2025, 17:59:22 UTC
Date Of Original Report
29 Jan 2025
Previous filing
18 Sep 2024
Next filing
18 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PCSA Common Stock 3,737 27 Jan 2025 Direct
holding PCSA Common Stock 12,400 27 Jan 2025 By Directed Trust Company FBO Justin Yorke IRA
holding PCSA Common Stock 31,232 27 Jan 2025 By Richland Fund, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Warrants Award $0 +12,400 $0.000000 12,400 29 Jan 2025 Common Stock 12,400 $0.6500 By Directed Trust Company FBO Justin Yorke IRA
transaction PCSA Warrants Award $0 +6,200 $0.000000 6,200 29 Jan 2025 Common Stock 6,200 $0.6500 By Directed Trust Company FBO Justin Yorke IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.